, 2020 La Dislipidemia Aterogénica (DA) es considerado un factor de riesgo cardiovascular, siendo uno de los trastornos metabólicos más comunes asociados a la obesidad y Síndrome Metabólico. En la literatura médica hay pocos estudios en población no diabética que demuestren la relación y predicción de DA con Índices antropométricos (IAs).
openaire +1 more source
Obesity and cardiovascular risk: a primer for the clinician. [PDF]
Arch Cardiol MexAraiza-Garaygordobil D +2 more
europepmc +1 more source
[Leuko-glycemic index as a marker of inflammation and endothelial dysfunction in overweight and obesity]. [PDF]
Rev Med Inst Mex Seguro SocVillalpando-Sánchez DC +1 more
europepmc +1 more source
[Effect of an exercise program on sedentary patients. Metabolic benefit and quality of life]. [PDF]
Aten Primaria, 2020 Lacuey Lecumberri G +3 more
europepmc +1 more source
[Clinical update and comprehensive approach to menopausal symptoms for healthcare professionals]. [PDF]
Rev Med Inst Mex Seguro SocBarrios-De Tomasi J, Pacheco-Chan MVLÁ.
europepmc +1 more source
Early-life adversity before age 5 is associated with reduced cardiometabolic health characterized by increased arterial stiffness and inflammation in adolescence. [PDF]
Health PsycholReid BM +6 more
europepmc +1 more source
El diálogo oculto entre el hueso y los tejidos a través del remodelado óseo. [PDF]
Adv Lab MedGonzález-Casaus ML.
europepmc +1 more source
Phytocompounds That Target White Adipose Tissue for Weight Loss: A Review Spanning From Ucp1 Induction in Rodents to Human Clinical Trials. [PDF]
Obes RevCoulter AA +4 more
europepmc +1 more source
[Cardiometabolic effects of weight loss]. [PDF]
Aten PrimariaGenua I, Sardà H, Pérez A.
europepmc +1 more source